Literature DB >> 6233888

Relative cost of coronary angioplasty and bypass surgery in a one-vessel disease model.

G C Jang, P C Block, M J Cowley, A R Gruentzig, G Dorros, D R Holmes, K M Kent, L L Leatherman, R K Myler, S M Sjolander.   

Abstract

A national study was carried out to determine the relative costs of PTCA and CABG. Baseline clinical criteria for the 2 groups were similar. Data were collected in 186 sets for the PTCA group and 175 sets for the CABG group. Male patients make up 81% of the PTCA group and 80% of the CABG group. Mean hospital stay was 12 +/- 5 days in the CABG group, compared with 4 +/- 2 days in the PTCA group (p less than 0.001). The base charges for hospital and professional components of the CABG procedure were $15,580 +/- $2,159, whereas the same charges for the PTCA procedure were $5,315 +/- $2,159 (p less than 0.001). With an 80% primary success rate, which was the group mean success rate, the average dollar savings per PTCA procedure would be $7,149, or $7,149,000 per 1,000 cases. Thus, PTCA for revascularization in 1-vessel CAD is significantly more cost-effective than CABG in the short term.

Entities:  

Mesh:

Year:  1984        PMID: 6233888     DOI: 10.1016/0002-9149(84)90746-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Percutaneous transluminal coronary angioplasty: state of the art and future directions.

Authors:  G S Roubin; A R Gruentzig
Journal:  Int J Card Imaging       Date:  1985

Review 2.  Coronary angioplasty.

Authors:  I C Cooper; M Signy; M M Webb-Peploe; D J Coltart
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

Review 3.  Cost comparisons of pharmacological strategies in open-heart surgery.

Authors:  Prabashni Reddy; Jessica Song
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Coronary artery bypass grafting: how much does it cost?

Authors:  H Krueger; J L Goncalves; F M Caruth; R I Hayden
Journal:  CMAJ       Date:  1992-01-15       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.